TEVA•benzinga•
Teva Pharmaceutical Sees Q1 EPS $0.52 Vs $0.51 Est.; Revenue $3.994B Vs $4.00B Est.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 27, 2025 by benzinga